Anxiolytic Effect of Progesterone is Mediated by the Neurosteroid Allopregnanolone at Brain GABA A Receptors
Abstract
Previous studies from this laboratory have shown that progesterone (PROG) treatment in ovariectomized rats produces an anti‐anxiety response similar to that observed after the administration of prototypical anxiolytic benzodiazepine (BDZ) compounds. The PROG‐induced anxiolytic response was highly correlated with an increased level of 3α‐hydroxy‐5α‐pregnan‐20‐one (allopregnanolone) in the blood and brain, and was also associated with a facilitation of GABA‐stimulated chloride ion (Cl − ) influx in cortical synaptoneurosomes. This correlative evidence suggested that the anxiolytic effect of PROG was a result of its in vivo reduction to the neuroactive steroid, allopregnanolone. In this report, a series of studies was conducted to determine the mechanism(s) by which PROG alters behavior in animal models of anxiety. In the first experiment, ovariectomized rats were injected with PROG (1 mg/0.2 ml, SC) 4 h prior to a test in the elevated plus‐maze. Some animals also received an injection of picrotoxin (0.75 mg/kg, IP), a GABA A receptor‐gated Cl − channel antagonist, whereas other animals were pretreated with RU 38486 (5 mg/0.2 ml, SC), a progestin receptor antagonist. PROG elicited anxiolytic behavior in the plus‐maze, an effect that was blocked by picrotoxin administration. Pretreatment with RU 38486 was not effective in altering PROG‐induced anxiolytic behavior in the plus‐maze. In a second experiment, the effect of PROG on behavior in the plus‐maze was determined in the presence of N,N‐diethyl‐4‐methyl‐3‐oxo‐4‐aza‐5α‐androstane‐17β‐carboxamide (4‐MA; 10 mg/0.2 ml, SC), a 5α‐reductase inhibitor. The enzyme inhibitor was potent in preventing the anxiolytic effect observed in the plus‐maze after PROG administration. In the defensive burying paradigm, PROG treatment also produced anxiolysis by reducing the duration of burying behavior, and this effect was prevented by 4‐MA pretreatment, but not by RU 38486 administration. After the completion of the behavioral assays, analysis of blood allopregnanolone levels revealed a marked increase in PROG‐treated females. The PROG‐induced elevation in circulating allopregnanolone was blocked by pretreatment with 4‐MA. In cortical synaptoneurosomes, the sensitivity (inverse of the EC 50 ) and the maximal response (Emax) in GABA‐stimulated 36 Cl − uptake were increased in PROG‐treated females. The potentiation of PROG on both of these neurochemical measures was not observed in animals pretreated with 4‐MA. Together, these studies provide evidence that the anxiolytic effect of PROG is not associated with an intracellular steroid receptor that initiates genomic‐mediated responses. The evidence is consistent with a nongenomic mechanism whereby PROG is metabolized to allopregnanolone, a neuroactive steroid that potentiates GABA A receptor‐mediated responses.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Progesterone produces its anxiolytic and hypnotic effects via allopregnanolone binding to GABAA receptors.
“Progesterone produces its anxiolytic/hypnotic effects via allopregnanolone's binding to GABAA-receptors [96, 97]”
From Sleep, hormones, and circadian rhythms throughout the menstrual cycle in healthy women and women with premenstrual dysphoric disorder (2010) · cites this paper as [97]
Cites
Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat
Pellow, S., Chopin, P., File, S. E., & Briley, M. (1985) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(85)90031-7 · Cited by 5,822 · see citing works
Paul, S. M., & Purdy, R. H. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.6.1347506 · Cited by 1,328 · see citing works
Majewska, M. D. (1992) · Progress in Neurobiology · doi:10.1016/0301-0082(92)90025-a · Cited by 1,087 · see citing works
[16] Protein determination in membrane and lipoprotein samples: Manual and automated procedures
Markwell, M. A. K., Haas, S. M., Tolbert, N. E., & BIEBER, L. L. (1981) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(81)72018-4 · Cited by 769 · see citing works
Neurosteroids act on recombinant human GABAA receptors
Puia, G., Santi, M., Vicini, S., Pritchett, D. B., Purdy, R. H., Paul, S. M., Seeburg, P. H., & Costa, E. (1990) · Neuron · doi:10.1016/0896-6273(90)90202-q · Cited by 519 · see citing works
Bitran, D., Hilvers, R. J., & Kellogg, C. K. (1991) · Brain Research · doi:10.1016/0006-8993(91)90761-j · Cited by 456 · see citing works
Self-citationConditioned defensive burying: A new paradigm for the study of anxiolytic agents
Treit, D., Pinel, J. P. J., & Fibiger, H. C. (1981) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(81)90219-7 · Cited by 420 · see citing works
PAPADOPOULOS, V. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-2-222 · Cited by 417 · see citing works
Corpechot, C., Young, J., Calvel, M., Wehrey, C., Veltz, J.-N., Touyer, G., Mouren, M.-C., Prasad, V. V., Banner, C., & Sjövall, J. (1993) · Endocrinology · doi:10.1210/endo.133.3.8365352 · Cited by 353 · see citing works
Morrow, A. L., Pace, J. R., Purdy, R. H., & Paul, S. M. (1990) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09958-4 · Cited by 333 · see citing works
Anticonvulsant profile of the progesterone metabolite 5α-pregnan-3α-ol-20-one
Belelli, D., Bolger, M. B., & Gee, K. W. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90077-0 · Cited by 323 · see citing works
Progesterone receptor-mediated effects of neuroactive steroids
Rupprecht, R., Reul, J. M. H. M., Trapp, T., van Steensel, B., Wetzel, C. H., Damm, K., Zieglgänsberger, W., & Holsboer, F. (1993) · Neuron · doi:10.1016/0896-6273(93)90156-l · Cited by 300 · see citing works
Anxiolytic activity of the progesterone metabolite 5α-pregnan-3α-ol-20-one
Wieland, S., Lan, N. C., Mirasedeghi, S., & Gee, K. W. (1991) · Brain Research · doi:10.1016/0006-8993(91)91658-n · Cited by 294 · see citing works
Bitran, D., Purdy, R. H., & Kellogg, C. K. (1993) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(93)90260-z · Cited by 260 · see citing works
Self-citationRadioimmunoassay of 3α-hydroxy-5α-pregnan-20-one in rat and human plasma
Purdy, R. H., Moore, P. H., Rao, P. N., Hagino, N., Yamaguchi, T., Schmidt, P. J., Rubinow, D. R., Morrow, A. L., & Paul, S. M. (1990) · Steroids · doi:10.1016/0039-128x(90)90031-6 · Cited by 204 · see citing works
Progesterone and the premenstrual syndrome: a double blind crossover trial.
Dennerstein, L., Spencer-Gardner, C., Gotts, G. H., Brown, J. B., Smith, M., & Burrows, G. D. (1985) · BMJ · doi:10.1136/bmj.290.6482.1617 · Cited by 192 · see citing works
Schwartz, R. D., Suzdak, P. D., & Paul, S. (1986) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10387-8 · Cited by 156 · see citing works
Gallo, M. A., & Smith, S. S. (1993) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(93)90219-j · Cited by 147 · see citing works
Response of Rat Ventral Prostate to a New and Novel 5αa-Reductase Inhibitor
Brooks, J. R., Baptista, E. M., BERMAN, C., Ham, E. A., Hichens, M., JOHNSTON, D. B. R., Primka, R. L., Rasmusson, G. H., Reynolds, G. F., Schmitt, S. M., et al. (1981) · Endocrinology · doi:10.1210/endo-109-3-830 · Cited by 143 · see citing works
Fernández‐Guasti, A., & Picazo, O. (1990) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(90)90044-i · Cited by 133 · see citing works
Landgren, S., Aasly, J. O., Bäckström, T. C., Dubrovsky, B. O., & DANIELSSON, E. (1987) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1987.tb08202.x · Cited by 120 · see citing works
Anxiolytics: Neurochemical, behavioral, and clinical perspectives
Honoré, T. (1983) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(83)90504-7 · Cited by 114 · see citing works
Bitran, D., Hilvers, R. J., & Kellogg, C. K. (1991) · Behavioral Neuroscience · doi:10.1037//0735-7044.105.5.653 · Cited by 111 · see citing works
Self-citationKavaliers, M., & Wiebe, J. P. (1987) · Brain Research · doi:10.1016/0006-8993(87)90228-9 · Cited by 111 · see citing works
Regulation of high-affinity GABAA receptors in the dorsal hippocampus by estradiol and progesterone
Schumacher, M., Coirini, H., & McEwen, B. S. (1989) · Brain Research · doi:10.1016/0006-8993(89)90955-4 · Cited by 103 · see citing works
Changes in burying behavior during the estrous cycle: Effect of estrogen and progesterone
Fernández‐Guasti, A., & Picazo, O. (1992) · Psychoneuroendocrinology · doi:10.1016/0306-4530(92)90027-5 · Cited by 103 · see citing works
Bitran, D., Hilvers, R. J., & Kellogg, C. K. (1991) · Behavioral Neuroscience · doi:10.1037/0735-7044.105.5.653 · Cited by 96 · see citing works
Self-citationEffect of ovarian hormones on conflict behavior
Rodriguez‐Sierra, J. F., Howard, J. L., Pollard, G. T., et al. (1984) · Psychoneuroendocrinology · doi:10.1016/0306-4530(84)90008-8 · Cited by 95 · see citing works
A placebo‐controlled study of effects of oral progesterone on performance and mood.
Ew, F., Weinstock, L. B., Rickels, K., Sondheimer, S. J., & Coutifaris, C. (1992) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1992.tb04038.x · Cited by 95 · see citing works
Norberg, L., Wahlström, G., & Bäckström, T. C. (1987) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1987.tb01770.x · Cited by 87 · see citing works
Etgen, A. M., & Barfield, R. J. (1986) · Endocrinology · doi:10.1210/endo-119-4-1610 · Cited by 87 · see citing works
Papadopoulos, V. (1993) · Endocrine Reviews · doi:10.1210/er.14.2.222 · Cited by 82 · see citing works
Finn, D. A., & Gee, K. W. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38251-0 · Cited by 78 · see citing works
ETHOLOGICALLY BASED ANIMAL MODELS OF ANXIETY DISORDERS
Lister, R. G. (1991) · Elsevier eBooks · doi:10.1016/b978-0-08-040698-5.50012-0 · Cited by 66 · see citing works
Steroid Effects on Neuronal Activity: When is the Genome Involved?
McEwen, B. S., Coirini, H., & Schumacher, M. (2007) · Novartis Foundation symposium · doi:10.1002/9780470513989.ch2 · Cited by 58 · see citing works
Progesterone inhibition of aggressive behaviors in hamsters
Fraile, I. G., McEwen, B. S., & Pfaff, D. W. (1987) · Physiology & Behavior · doi:10.1016/0031-9384(87)90013-8 · Cited by 51 · see citing works
Evidence that 5α-pregnan-3α-ol-20-one is the metabolite responsible for progesterone anesthesia
Mok, W. M., & Krieger, N. R. (1990) · Brain Research · doi:10.1016/0006-8993(90)91792-f · Cited by 45 · see citing works
Regulation of central and peripheral benzodiazepine receptors in progesterone-treated rats
Gavish, M., Weizman, A., Youdim, M. B. H., & Okun, F. (1987) · Brain Research · doi:10.1016/0006-8993(87)90728-1 · Cited by 43 · see citing works
Steroid Hormones and Receptors of the GABA A Supramolecular Complex
Canonaco, M., Carelli, A., & Maggi, A. C. (2008) · Neuroendocrinology · doi:10.1159/000126461 · Cited by 38 · see citing works
Canonaco, M., O’Connor, L. H., Pfaff, D. W., et al. (1989) · Experimental Brain Research · doi:10.1007/bf00249916 · Cited by 38 · see citing works
The premenstrual syndrome. New views
Rubinow, D. R. (1992) · JAMA · doi:10.1001/jama.268.14.1908 · Cited by 38 · see citing works
In Vivo Studies Identify 5a‐Pregnan‐3a‐o1‐20‐one as an Active Anesthetic Agent
Mok, W. M., Herschkowitz, S., & Krieger, N. R. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb08293.x · Cited by 37 · see citing works
Steroid Hormones and Receptors of the GABA A Supramolecular Complex
Canonaco, M., Tavolaro, R., & Maggi, A. C. (2008) · Neuroendocrinology · doi:10.1159/000126462 · Cited by 34 · see citing works
Functional changes in GABAAreceptor stimulation during the oestrous cycle of the rat
Westerling, P., Lindgren, S., & Meyerson, B. J. (1991) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1991.tb09830.x · Cited by 29 · see citing works
Contijoch, A. M., Malamed, S., Sarkar, D. K., et al. (2008) · Neuroendocrinology · doi:10.1159/000126381 · Cited by 21 · see citing works
Canonaco, M., Valenti, A., & Maggi, A. C. (1990) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(90)90008-6 · Cited by 18 · see citing works
5-HT agonists, 5-HT antagonists and benzodiazepines: Their comparative behavioural pharmacology
File, S. E. (1991) · European Neuropsychopharmacology · doi:10.1016/0924-977x(91)90013-k · Cited by 3 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Phasic vs Sustained Fear in Rats and Humans: Role of the Extended Amygdala in Fear vs Anxiety
Davis, M., Walker, D. L., Miles, L., & Grillon, C. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.109 · Cited by 1,488 · see citing works
Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety
Walker, D. L., Toufexis, D. J., & Davis, M. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01282-2 · Cited by 838 · see citing works
Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties
Rupprecht, R. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00064-1 · Cited by 427 · see citing works
Compagnone, N. A., & Mellon, S. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4678 · Cited by 327 · see citing works
Transgenerational Epigenetic Programming of the Brain Transcriptome and Anxiety Behavior
Skinner, M. K., Anway, M. D., Savenkova, M. I., Gore, A. C., & Crews, D. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003745 · Cited by 293 · see citing works
Progesterone selectively increases amygdala reactivity in women
van Wingen, G. A., van Broekhoven, F., Verkes, R. J., Petersson, K. M., Bäckström, T., Buitelaar, J. K., & Fernández, G. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002030 · Cited by 273 · see citing works
Shechter, A., & Boivin, D. B. (2010) · International Journal of Endocrinology · doi:10.1155/2010/259345 · Cited by 194 · see citing works
Serum allopregnanolone in women with postpartum “blues”
Nappi, R. (2001) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(00)01112-1 · Cited by 166 · see citing works
GABAA receptor-acting neurosteroids: a role in the development and regulation of the stress response
Gunn, B. G., Cunningham, L., Mitchell, S. G., Swinny, J. D., Lambert, J. J., & Belelli, D. (2015) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.06.001 · Cited by 149 · see citing works
Neurosteroids in the context of stress: implications for depressive disorders
Girdler, S. S., & Klatzkin, R. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.05.006 · Cited by 148 · see citing works
Beyond the HPA Axis: Progesterone-Derived Neuroactive Steroids in Human Stress and Emotion
Wirth, M. M. (2011) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00019 · Cited by 121 · see citing works
Hormonal, cardiovascular, and subjective responses to acute stress in smokers
Childs, E., & de Wit, H. (2009) · Psychopharmacology · doi:10.1007/s00213-008-1359-5 · Cited by 97 · see citing works
The Relationship of Sex Hormones and Cortisol with Cognitive functioning in Schizophrenia
Halari, R., Kumari, V., Mehrotra, R., Wheeler, M., Hines, M., & Sharma, T. (2004) · Journal of Psychopharmacology · doi:10.1177/026988110401800307 · Cited by 82 · see citing works
Hardoy, M. C., Serra, M., Carta, M. G., Contu, P., Pisu, M. G., & Biggio, G. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000229483.52955.ec · Cited by 80 · see citing works
Allopregnanolone modulation of HPA axis function in the adult rat
Biggio, G., Pisu, M. G., Biggio, F., & Serra, M. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3521-6 · Cited by 40 · see citing works
Koonce, C. J., & Frye, C. A. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.07.025 · Cited by 23 · see citing works
- Authors
- Bitran, D., Shiekh, M., & McLeod, M.
- Affiliations
- College of the Holy Cross (US)
- Corresponding author
- Bitran, Daniel
- Venue
- Journal of Neuroendocrinology
- Publisher
- Wiley
- Published
- 1995-03
- Volume
- 7
- Issue
- 3
- Pages
- 171-177
- ISSN
- 0953-8194 (ISSN-L)
- 1365-2826
- OpenAlex
- W1994924064
- Cited by
- 388
- References
- 47
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 4 · 2023: 8 · 2022: 10 · 2021: 9 · 2020: 7 · 2019: 12 · 2018: 8 · 2017: 7 · 2016: 12 · 2015: 8 · 2014: 13 · 2013: 14 · 2012: 9
- FWCI
- 3.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Neuroendocrinology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r29mh050450-03)
- Merck Sharp and Dohme
- National Institute of Mental Health (MH50450)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- progesterone, allopregnanolone, neurosteroids, anxiolytic effects, GABAA receptor, 5α-reductase inhibition, mifepristone, progestin receptor, picrotoxin, elevated plus maze, defensive burying, ovariectomy, benzodiazepines
- MeSH terms
- Analysis of Variance, Animals, Azasteroids, Brain, Estrus, Female, Ovariectomy, Ovary, Oxidoreductases, Picrotoxin, Pregnanolone, Progesterone, Receptors, GABA-A, Dihydrotestosterone, Anti-Anxiety Agents, Mifepristone, Cholestenone 5 alpha-Reductase, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
